cancer

Astellas innovation awards offer up ideas to ease cancer patients' pandemic burdens
Astellas innovation awards offer up ideas to ease cancer patients' pandemic burdens
Fierce Pharma
Astellas
cancer
innovation
Flag link:
OrbiMed-incubated Theseus unveils $100M to beat cancer drug resistance
OrbiMed-incubated Theseus unveils $100M to beat cancer drug resistance
MedCity News
OrbiMed
Ariad Pharmaceuticals
Theseus Pharmaceuticals
cancer
Flag link:
Boehringer and MD Anderson extend KRAS cancer collaboration
Boehringer and MD Anderson extend KRAS cancer collaboration
Pharmaforum
Boehringer Ingelheim
MD Anderson
KRAS
cancer
Flag link:
AZ aims at Pfizer, GSK with potential new PARP cancer drug
AZ aims at Pfizer, GSK with potential new PARP cancer drug
Pharmaforum
AstraZeneca
PARP inhibitors
Pfizer
GSK
cancer
Lynparza
Flag link:
ASCO-Friends meeting: NCI offers strategies to modernize cancer trials
ASCO-Friends meeting: NCI offers strategies to modernize cancer trials
RAPS.org
ASCO
cancer
clinical trials
Flag link:
Lilly gene-targeted drug shows potential for use across cancers
Lilly gene-targeted drug shows potential for use across cancers
BioPharma Dive
Eli Lilly
AAACR
Retevmo
cancer
clinical trials
Flag link:
With $44M and Microsoft R&D alliance, Volastra takes aim at metastatic cancers
With $44M and Microsoft R&D alliance, Volastra takes aim at metastatic cancers
MedCity News
Volastra Therapeutics
cancer metastasis
cancer
R&D
Microsoft
funding
Flag link:
Invitae borrows against the future
Invitae borrows against the future
EP Vantage
Invitae
cancer
liquid biopsy
M&A
Flag link:
Why Surface Oncology Is Flying Higher After Hours Today
Why Surface Oncology Is Flying Higher After Hours Today
Motley Fool
Surface Oncology
FDA
cancer
regulatory
Flag link:
Omega Therapeutics adds $126M to move “programmable” drugs closer to the clinic
Omega Therapeutics adds $126M to move “programmable” drugs closer to the clinic
MedCity News
Omega Therapeutics
R&D
programmable drugs
cancer
Flag link:
Boehringer’s big cancer reveal draws near
Boehringer’s big cancer reveal draws near
EP Vantage
Boehringer Ingelheim
AACR
cancer
oncology
KRAS
Flag link:
As Alkermes shines light on early cancer, neuro assets, biotech searches for collabs, strategic ops
As Alkermes shines light on early cancer, neuro assets, biotech searches for collabs, strategic ops
Fierce Biotech
Alkermes
R&D
cancer
immuno-oncology
Flag link:
Asher Bio adds $55M and takes a page from nature for cancer immunotherapy
Asher Bio adds $55M and takes a page from nature for cancer immunotherapy
MedCity News
Interluekin-2
Asher Bio
cancer
cancer immunotherapy
Flag link:
CAR-M era begins as Carisma doses first patient
CAR-M era begins as Carisma doses first patient
Endpoints
Carisma Therapeutics
clinical trials
cancer
CAR-M
cell therapy
Flag link:
No knockout blow from Rubius
No knockout blow from Rubius
EP Vantage
Rubius Therapeutics
RTX-240
clinical trials
cancer
Flag link:
Spectrum Pharma Climbs as FDA to Fast-Track Cancer Drug Review
Spectrum Pharma Climbs as FDA to Fast-Track Cancer Drug Review
TheStreet.com
Spectrum Pharma
FDA
fast track status
cancer
Flag link:
Inovio’s reinvention falls flat
Inovio’s reinvention falls flat
EP Vantage
Inovio
VGX-3100
cancer vaccines
cancer
Flag link:
Xilio raises $95M to take twists on Yervoy and IL-2 into clinic
Xilio raises $95M to take twists on Yervoy and IL-2 into clinic
Fierce Biotech
Xilio Therapeutics
funding
immunotherapy
clinical trials
cancer
oncology
Yervoy
Flag link:
An mRNA vaccine delivered in hydrogel shows promise as a durable cancer immunotherapy
An mRNA vaccine delivered in hydrogel shows promise as a durable cancer immunotherapy
Fierce Biotech
MRNA
vaccines
hydrogels
cancer
Flag link:
Novartis’s canakinumab cancer test approaches
Novartis’s canakinumab cancer test approaches
EP Vantage
Novartis
Regeneron
canakinumab
cancer
non-small cell lung cancer
Flag link:

Pages